Rh Immunoglobulin, also known as RhIg, is a blood product used to prevent Rh incompatibility in individuals who are Rh-negative. This condition can arise during pregnancy when an Rh-negative mother carries an Rh-positive fetus, potentially leading to hemolytic disease of the newborn (HDN).